Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A

Besse, B., Goto, K., Wang, Y., Lee, S.-H., Marmarelis, M. E., Ohe, Y., Caro, R. B., Kim, D.-W., Lee, J.-S., Cousin, S., Ichihara, E., Li, Y., Paz-Ares, L., Ono, A., Sanborn, R. E., Watanabe, N., Jose de Miguel, M., Helissey, C., Shu, C. A., … Cho, B. C. (2025). Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2024.12.029
Authors:
Benjamin Besse
Koichi Goto
Yongsheng Wang
Se-Hoon Lee
Melina E Marmarelis
Yuichiro Ohe
Reyes Bernabe Caro
Dong-Wan Kim
Jong-Seok Lee
Sophie Cousin
Eiki Ichihara
Yongsheng Li
Luis Paz-Ares
Akira Ono
Rachel E Sanborn
Naohiro Watanabe
Maria Jose de Miguel
Carole Helissey
Catherine A Shu
Alexander I Spira
Pascale Tomasini
James Chih-Hsin Yang
Yiping Zhang
Enriqueta Felip
Frank Griesinger
Saiama N Waqar
Antonio Calles
Joel W Neal
Christina S Baik
Pasi A Jänne
S Martin Shreeve
Joshua C Curtin
Bharvin Patel
Michael Gormley
Xuesong Lyu
Jun Chen
Pei-Ling Chu
Janine Mahoney
Leonardo Trani
Joshua M Bauml
Meena Thayu
Roland E Knoblauch
Byoung Chul Cho
Affiliated Authors:
Catherine A Shu
Columbia Affiliation:
Author Keywords:
nsclc
amivantamab
lazertinib
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtho.2024.12.029
PMID:
39755170
DOI:
10.1016/j.jtho.2024.12.029
Journal:
Journal of Thoracic Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: